GSK Set for $500 Million Payment From mRNA Lawsuit Settlement

Biotech Law | Intellectual Property | Business Litigation Introduction: A Settlement Years in the Making In a significant resolution to one of the most closely watched biotechnology IP battles, CureVac NV has reached a settlement with Pfizer Inc. and BioNTech SE over allegations of patent infringement related to mRNA vaccine technology.

Harmless Cooling: Global Environmental Implications of Latvia’s AC Innovation

The air conditioning (AC) industry, long reliant on chemical refrigerants with high global warming potential (GWP), is undergoing a much-needed transformation. Recently, Latvia has emerged as a surprising frontrunner in sustainable HVAC (heating, ventilation, and air conditioning) innovation. New technologies—such as condenser direct evaporative cooling and the increasing use of under-floor

Understanding Intellectual Property in the Age of Technology

As technology continues to advance at an unprecedented pace, the landscape of intellectual property (IP) law is also evolving rapidly. From artificial intelligence (AI) to blockchain and genetic engineering, new technologies are reshaping how intellectual property is created, protected, and monetized. As a result, businesses, innovators, and legal professionals must